One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   South America Nuclear Imaging Market

South America Nuclear Imaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)


Product Code : MDHC00121911
Survey : Mordor Intelligence
Publish On : 12, August, 2022
Category : Healthcare and Pharmaceuticals
Study Area : North America (U.S. and Others), Europe (Germany, France, U.K. and Others), Asia-Pacific (Japan, China, India and Others), Rest of World (Brazil, Rest of Latin America, Middle East & Others)
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6750 / Question Form
Enterprise User USD9000 / Question Form
 - Canon Medical Systems Corporation
- Koninklijke Philips NV
- GE Healthcare
- NTP Radioisotopes SOC
- Bruker Corporation
- Bracco Imaging SpA
- Siemens Healthineers

[Report Description]

The factors that are propelling the growth of the South American market include increasing diagnostic applications in various diseases, such as cancer and cardiovascular diseases, government support, and a shift from standalone to hybrid modalities, and a rise in prevalence of cancer and cardiac disorders in the region.



Nuclear imaging has applications at various stages of inpatient management processes, such as diagnosis, staging, therapy delivery, and its follow-ups. The primary role of imaging has been diagnostics, but it is increasing slowly for interventional diagnostics and therapeutic uses. However, the lack of proper reimbursement, shortage of the radioisotopes, stringent regulations restraint the market growth in the region.



Key Market Trends



Oncology is Expected to Have the Highest CAGR in the Forecast Period



The prevalence of various types of cancer in South America has shown a significant rise over the past two decades. The FDG-PET/CT is more sensitive than contrast-enhanced CT scan in the staging of several types of lymphoma or in detecting tumor dissemination in several solid cancers, such as breast cancer, lung cancer, and colon cancer. The introduction of sophisticated software to use PET scan as a biomarker has facilitated new ways to calculate new prognostic markers, such as the metabolic tumor volume (MTV) and the total amount of tumor glycolysis (TLG). The 18F-fluorodeoxyglucose (18F-FDG) has high sensitivity. This technique can be used for the imaging of lung cancer, lymphoma, head and neck tumors, breast cancer, esophageal cancer, colorectal cancer, and urinary tract tumors.



As per the report of the National Institute of Health, in Brazil, cancer is the second most common cause of death, after cardiovascular diseases. In addition according to the estimates of the Globocan 2018, there will be 559,371 new cases of cancer in Brazil. Hence, all the aforementioned factors are expected to drive the growth of the market.



Competitive Landscape



As per the scope of the report, the nuclear imaging market is highly competitive and consists of a few major players. In terms of market share, few of the major players currently dominate the market. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments.



Additional Benefits:



  • The market estimate (ME) sheet in Excel format

  • 3 months of analyst support

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Prevalence of Cancer and Cardiac Disorders
4.2.2 Increase in Technological Advancements
4.3 Market Restraints
4.3.1 Limited Reimbursement and Stringent Regulatory Procedures
4.4 Porter s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Equipment
5.1.2 Radioisotope
5.1.2.1 SPECT Radioisotopes
5.1.2.1.1 Technetium-99m (TC-99m)
5.1.2.1.2 Thallium-201 (TI-201)
5.1.2.1.3 Gallium (Ga-67)
5.1.2.1.4 Iodine (I-123)
5.1.2.1.5 Other SPECT Radioisotopes
5.1.2.2 PET Radioisotopes
5.1.2.2.1 Fluorine-18 (F-18)
5.1.2.2.2 Rubidium-82 (RB-82)
5.1.2.2.3 Other PET Radioisotopes
5.2 By Application
5.2.1 SPECT Applications
5.2.1.1 Cardiology
5.2.1.2 Neurology
5.2.1.3 Thyroid
5.2.1.4 Other SPECT Applications
5.2.2 PET Applications
5.2.2.1 Oncology
5.2.2.2 Cardiology
5.2.2.3 Neurology
5.2.2.4 Other PET Applications
5.3 Geography
5.3.1 South America
5.3.1.1 Brazil
5.3.1.2 Argentina
5.3.1.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Canon Medical Systems Corporation
6.1.2 Koninklijke Philips NV
6.1.3 GE Healthcare
6.1.4 NTP Radioisotopes SOC
6.1.5 Bruker Corporation
6.1.6 Bracco Imaging SpA
6.1.7 Siemens Healthineers

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports

+